Cutaneous involvement account for the majority of drug-related adverse events. During recent years the introduction of novel ...

To explore complications related to anesthetics, adverse event reports from the U.S. Food and Drug Administration Adverse Event Reporting ... Of these cases, a significantly higher risk of serious ...

Researchers from Queen Mary University of London (QMUL) found that 9% of all adverse drug reactions (ADRs) reported to the Yellow Card database are associated with medications where genetic ...

During a recently conducted analysis of adverse drug reactions (ADRs), the commission found that the use of these drugs can cause severe reactions, including muscle spasms. The government body has ...

Previous studies have indicated that more than 99% of individuals have genetic variants which could lead to an adverse response to certain drugs. In some cases, these reactions can be serious and ...

NEW DELHI: The All India Institute of Medical Sciences (AIIMS), New Delhi, has established a dedicated committee to monitor and report adverse events related to drugs and medical devices used in ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

Per Pubmed, a medical journal, 77 adverse drug reactions were reported in India last year—30.55% higher than in the year before. Till September this year, about 10 cases of adverse drug ...

The icons and color coding utilized in this figure adhere ... are more frequently associated with adverse drug reactions (31). However, the latest meta-analysis shows no difference in safety between ...

Medication harm or adverse drug reactions (ADRs) are much more common than might be expected. One new study by researchers at the Royal College of Surgeons of Ireland (RCSI) has found that an ADR ...

Government has issued alert about an adverse reaction of Meftal. The syndrome causes a diverse array of symptoms, from 2 to 8 weeks after initiating the drug. The Indian Pharmacopoeia Commission ...